
Axsome Therapeutics Inc
NASDAQ:AXSM

Intrinsic Value
The intrinsic value of one
AXSM
stock under the Base Case scenario is
136.362
USD.
Compared to the current market price of 116.835 USD,
Axsome Therapeutics Inc
is
Undervalued by 14%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Axsome Therapeutics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
Axsome Therapeutics Inc
Balance Sheet Decomposition
Axsome Therapeutics Inc
Current Assets | 485.1m |
Cash & Short-Term Investments | 315.4m |
Receivables | 142m |
Other Current Assets | 27.7m |
Non-Current Assets | 83.4m |
PP&E | 6m |
Intangibles | 58.9m |
Other Non-Current Assets | 18.5m |
Free Cash Flow Analysis
Axsome Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Axsome Therapeutics Inc
Revenue
|
385.7m
USD
|
Cost of Revenue
|
-33.3m
USD
|
Gross Profit
|
352.4m
USD
|
Operating Expenses
|
-633m
USD
|
Operating Income
|
-280.6m
USD
|
Other Expenses
|
-6.7m
USD
|
Net Income
|
-287.2m
USD
|
AXSM Profitability Score
Profitability Due Diligence
Axsome Therapeutics Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Score
Axsome Therapeutics Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.
AXSM Solvency Score
Solvency Due Diligence
Axsome Therapeutics Inc's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Score
Axsome Therapeutics Inc's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AXSM Price Targets Summary
Axsome Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
AXSM
is 180.158 USD
with a low forecast of 149.48 USD and a high forecast of 222.6 USD.
Dividends
Current shareholder yield for AXSM is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
AXSM
stock under the Base Case scenario is
136.362
USD.
Compared to the current market price of 116.835 USD,
Axsome Therapeutics Inc
is
Undervalued by 14%.